143 related articles for article (PubMed ID: 38855032)
1. Rapid and Remarkable Response to Rituximab in a Case of Lupus Enteritis: Challenging the Norm.
Hussein AH; Altamimi BL
Mediterr J Rheumatol; 2024 Mar; 35(1):187-191. PubMed ID: 38855032
[TBL] [Abstract][Full Text] [Related]
2. Lupus enteritis as the only active manifestation of systemic lupus erythematosus: A case report.
Gonzalez A; Wadhwa V; Salomon F; Kaur J; Castro FJ
World J Clin Cases; 2019 Jun; 7(11):1315-1322. PubMed ID: 31236395
[TBL] [Abstract][Full Text] [Related]
3. Acute abdominal pain in systemic lupus erythematosus: focus on lupus enteritis (gastrointestinal vasculitis).
Lee CK; Ahn MS; Lee EY; Shin JH; Cho YS; Ha HK; Yoo B; Moon HB
Ann Rheum Dis; 2002 Jun; 61(6):547-50. PubMed ID: 12006332
[TBL] [Abstract][Full Text] [Related]
4. Dramatic Response of Lupus Enteritis, Nephritis, and Pancytopenia to Plasmapheresis and Rituximab.
Aftab A; Saleem N; Abbas SF; Ullah Z; Haneef M
Case Rep Gastrointest Med; 2022; 2022():3443141. PubMed ID: 35706566
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of belimumab combined with rituximab in severe systemic lupus erythematosus: study protocol for the phase 3, multicenter, randomized, open-label Synbiose 2 trial.
van Schaik M; Arends EJ; Soonawala D; van Ommen E; de Leeuw K; Limper M; van Paassen P; Huizinga TWJ; Toes REM; van Kooten C; Rotmans JI; Rabelink TJ; Teng YKO
Trials; 2022 Nov; 23(1):939. PubMed ID: 36371234
[TBL] [Abstract][Full Text] [Related]
6. Enteritis: a window to the diagnosis of systemic lupus erythematosus in an adolescent girl: case report.
Patel A; Krishnapura Lakshminarayana S; Kumble D; Kariyappa M; Ramkumar G; Anilkumar H; Bhattad S
Paediatr Int Child Health; 2024 May; 44(1):42-47. PubMed ID: 38184810
[TBL] [Abstract][Full Text] [Related]
7. Bilateral retinal vasculitis in a patient with systemic lupus erythematosus and its remission with rituximab therapy.
Hickman RA; Denniston AK; Yee CS; Toescu V; Murray PI; Gordon C
Lupus; 2010 Mar; 19(3):327-9. PubMed ID: 19900982
[TBL] [Abstract][Full Text] [Related]
8. B-cell-targeted therapy for systemic lupus erythematosus.
Sabahi R; Anolik JH
Drugs; 2006; 66(15):1933-48. PubMed ID: 17100405
[TBL] [Abstract][Full Text] [Related]
9. Current role of rituximab in systemic lupus erythematosus.
Mok CC
Int J Rheum Dis; 2015 Feb; 18(2):154-63. PubMed ID: 25522652
[TBL] [Abstract][Full Text] [Related]
10. [Abdominal pain due to lupus enteritis: a rare cause for a frequent complaint].
Coutinho M; Inês L; Malcata A
Acta Reumatol Port; 2009; 34(2B):405-8. PubMed ID: 19727052
[TBL] [Abstract][Full Text] [Related]
11. Lupus enteritis as the sole presenting feature of systemic lupus erythematosus: case report and review of the literature.
Chowichian M; Aanpreung P; Pongpaibul A; Charuvanij S
Paediatr Int Child Health; 2019 Nov; 39(4):294-298. PubMed ID: 30191770
[TBL] [Abstract][Full Text] [Related]
12. Rituximab in systemic lupus erythematosus and lupus nephritis.
Beckwith H; Lightstone L
Nephron Clin Pract; 2014; 128(3-4):250-4. PubMed ID: 25471633
[TBL] [Abstract][Full Text] [Related]
13. [Systemic lupus erythematosus associated macrophage activation syndrome with neuropsychiatric symptoms: A report of 2 cases].
Luo ZJ; Wu JJ; Song Y; Mei CL; DU R
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):1111-1117. PubMed ID: 38101797
[TBL] [Abstract][Full Text] [Related]
14. The NET-effect of combining rituximab with belimumab in severe systemic lupus erythematosus.
Kraaij T; Kamerling SWA; de Rooij ENM; van Daele PLA; Bredewold OW; Bakker JA; Bajema IM; Scherer HU; Toes REM; Huizinga TJW; Rabelink TJ; van Kooten C; Teng YKO
J Autoimmun; 2018 Jul; 91():45-54. PubMed ID: 29636274
[TBL] [Abstract][Full Text] [Related]
15. A multicenter phase I/II trial of rituximab for refractory systemic lupus erythematosus.
Tanaka Y; Yamamoto K; Takeuchi T; Nishimoto N; Miyasaka N; Sumida T; Shima Y; Takada K; Matsumoto I; Saito K; Koike T
Mod Rheumatol; 2007; 17(3):191-7. PubMed ID: 17564773
[TBL] [Abstract][Full Text] [Related]
16. Shrinking lung syndrome treated with rituximab in pediatric systemic lupus erythematosus: a case report and review of the literature.
DeCoste C; Mateos-Corral D; Lang B
Pediatr Rheumatol Online J; 2021 Jan; 19(1):7. PubMed ID: 33407629
[TBL] [Abstract][Full Text] [Related]
17. [Rituximab (anti-CD20 monoclonal antibody) for refractory systemic lupus erythematosus: report of one case].
Sabugo F; Llanos C; Soto L; Gutiérrez J; Cuchacovich M
Rev Med Chil; 2005 Jun; 133(6):681-4. PubMed ID: 16075133
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of anti-CD20 antibody rituximab for patients with refractory systemic lupus erythematosus.
Iwata S; Saito K; Hirata S; Ohkubo N; Nakayamada S; Nakano K; Hanami K; Kubo S; Miyagawa I; Yoshikawa M; Miyazaki Y; Yoshinari H; Tanaka Y
Lupus; 2018 Apr; 27(5):802-811. PubMed ID: 29308726
[TBL] [Abstract][Full Text] [Related]
19. A case of "refractory" lupus erythematosus profundus responsive to rituximab [case report].
McArdle A; Baker JF
Clin Rheumatol; 2009 Jun; 28(6):745-6. PubMed ID: 19343472
[TBL] [Abstract][Full Text] [Related]
20. Predictors and prognostic factors influencing outcomes of anti-CD20 monoclonal antibodies in systemic lupus erythematosus: A systematic review update.
Rodziewicz M; Mendoza-Pinto C; Dyball S; Munguía-Realpozo P; Parker B; Bruce IN
Semin Arthritis Rheum; 2024 Apr; 65():152346. PubMed ID: 38185077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
